Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src. (Q42800257)

7 November 2017

title

Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src. (English)

1 reference

7 November 2017

Nakaigawa N

1

1 reference

7 November 2017

Weirich G

series ordinal

2

1 reference

7 November 2017

Schmidt L

series ordinal

3

1 reference

7 November 2017

Zbar B

series ordinal

4

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

7 November 2017

1 reference

7 November 2017

volume

19

1 reference

7 November 2017

issue

26

1 reference

7 November 2017

page(s)

2996-3002

1 reference

Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

The protein-tyrosine kinase substrate, p81, is homologous to a chicken microvillar core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Association of p60src with Triton X-100-resistant cellular structure correlates with morphological transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Activating mutations for the met tyrosine kinase receptor in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Talin is phosphorylated on tyrosine in chicken embryo fibroblasts transformed by Rous sarcoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Vinculin: A cytoskeletal target of the transforming protein of rous sarcoma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Paxillin: a new vinculin-binding protein present in focal adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Identification and characterization of a novel cytoskeleton-associated pp60src substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

Molecular cytogenetics of renal cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

inferred from DOI database lookup

7 January 2021

based on heuristic

Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

inferred from DOI database lookup

7 January 2021

based on heuristic

Hereditary papillary renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203628

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1203628

1 reference

Dimensions Publication ID

7 November 2017

1012488570

0 references

1 reference